[ { "@id": "http://purl.org/np/RAR-tJ15lI05dwure_3KQQxnW_NllPsgGDasHyvDCMRsc#assertion", "@graph": [ { "@id": "http://purl.obolibrary.org/obo/DOID_2983", "https://w3id.org/biolink/vocab/category": [ { "@id": "https://w3id.org/biolink/vocab/Disease" } ] }, { "@id": "http://purl.org/np/RAR-tJ15lI05dwure_3KQQxnW_NllPsgGDasHyvDCMRsc#association", "http://www.w3.org/1999/02/22-rdf-syntax-ns#object": [ { "@id": "http://purl.obolibrary.org/obo/DOID_2983" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate": [ { "@id": "https://w3id.org/biolink/vocab/treats" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject": [ { "@id": "https://identifiers.org/drugbank:DB00421" } ], "@type": [ "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement" ], "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "Spironolactone, USP is contraindicated for patients with anuria, acute renal insufficiency, significant impairment of renal excretory function, hyperkalemia, Addison's disease or other conditions associated with hyperkalemia, and with concomitant use of eplerenone." } ], "https://w3id.org/biolink/vocab/provided_by": [ { "@id": "https://w3id.org/um/NeuroDKG" } ], "https://w3id.org/biolink/vocab/relation": [ { "@id": "https://schema.org/MedicalContraindication" } ] }, { "@id": "https://identifiers.org/drugbank:DB00421", "https://w3id.org/biolink/vocab/category": [ { "@id": "https://w3id.org/biolink/vocab/Drug" } ] } ] }, { "@id": "http://purl.org/np/RAR-tJ15lI05dwure_3KQQxnW_NllPsgGDasHyvDCMRsc#provenance", "@graph": [ { "@id": "http://purl.org/np/RAR-tJ15lI05dwure_3KQQxnW_NllPsgGDasHyvDCMRsc#assertion", "http://www.w3.org/ns/prov#wasAttributedTo": [ { "@id": "https://orcid.org/0000-0002-1468-3557" } ] } ] }, { "@id": "http://purl.org/np/RAR-tJ15lI05dwure_3KQQxnW_NllPsgGDasHyvDCMRsc#pubinfo", "@graph": [ { "@id": "http://purl.org/np/RAR-tJ15lI05dwure_3KQQxnW_NllPsgGDasHyvDCMRsc#sig", "http://purl.org/nanopub/x/hasAlgorithm": [ { "@value": "RSA" } ], "http://purl.org/nanopub/x/hasPublicKey": [ { "@value": "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" } ], "http://purl.org/nanopub/x/hasSignature": [ { "@value": "auEurIPrGr9yXEpJMCMRLd0lRDJU8yFGjX/G2fcCpmsdMJKPz+cuu9dKdQJjOEI6dvxnQ6kbzjZHTb53a9g66f/wVfxHY5IVMo2V5mqYm6TIiH4jdvJgsOU1dYI3v0E3PL+YXtKtZb4oKoWXLOBCpXTYHDuNQaE314xk52E7NDA=" } ], "http://purl.org/nanopub/x/hasSignatureTarget": [ { "@id": "http://purl.org/np/RAR-tJ15lI05dwure_3KQQxnW_NllPsgGDasHyvDCMRsc" } ] }, { "@id": "http://purl.org/np/RAR-tJ15lI05dwure_3KQQxnW_NllPsgGDasHyvDCMRsc", "http://purl.org/dc/terms/created": [ { "@value": "2021-08-16T14:59:28.763+02:00", "@type": "http://www.w3.org/2001/XMLSchema#dateTime" } ], "http://purl.org/dc/terms/creator": [ { "@id": "https://orcid.org/0000-0002-1468-3557" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate": [ { "@id": "http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate": [ { "@id": "http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate": [ { "@id": "http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY" } ] } ] }, { "@id": "http://purl.org/np/RAR-tJ15lI05dwure_3KQQxnW_NllPsgGDasHyvDCMRsc#Head", "@graph": [ { "@id": "http://purl.org/np/RAR-tJ15lI05dwure_3KQQxnW_NllPsgGDasHyvDCMRsc", "http://www.nanopub.org/nschema#hasAssertion": [ { "@id": "http://purl.org/np/RAR-tJ15lI05dwure_3KQQxnW_NllPsgGDasHyvDCMRsc#assertion" } ], "http://www.nanopub.org/nschema#hasProvenance": [ { "@id": "http://purl.org/np/RAR-tJ15lI05dwure_3KQQxnW_NllPsgGDasHyvDCMRsc#provenance" } ], "http://www.nanopub.org/nschema#hasPublicationInfo": [ { "@id": "http://purl.org/np/RAR-tJ15lI05dwure_3KQQxnW_NllPsgGDasHyvDCMRsc#pubinfo" } ], "@type": [ "http://www.nanopub.org/nschema#Nanopublication" ] } ] } ]